Sample management solutions for pharma and biotech firms

Our niche expertise in serving the pharmaceutical and biotechnology industries stems from highly trained team members with decades of experience. We support the entire drug development process from target identification to commercialization.

Pharmaceutical and biotech firms face numerous potential risks without proper sample management—and they are accompanied by costly consequences:

• Studies may have to be rerun for compliance, data or drug safety reasons
• Intellectual property may be lost
• Approvals may be delayed or jeopardized

With these delays, millions of dollars are at risk—both in costs to recreate information and in the loss of peak sales.

Life science companies can also directly benefit from retrospective validation of biomarkers, and testing for prevalence of biomarkers and specified populations.